Long-Term Outcomes of Recipients of Liver Transplants from Living Donors Treated with a Very Low-Calorie Diet.

Hannah Wozniak, Sara Naimimohasses, Toru Goto, Gonzalo Sapisochin, Blayne Sayed, Anand Ghanekar, Mark Cattral, Nazia Selzner

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Journal of transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hannah WozniakInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.

Sara NaimimohassesMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Toru GotoMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Gonzalo SapisochinMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Blayne SayedMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Anand GhanekarMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Mark CattralMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Nazia SelznerMulti-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-9435-2597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of steatotic liver disease (SLD) in potential living donors is concerning, as it limits donor's availability amid rising demand. OPTIFAST very low-calorie diet (VLCD), a meal replacement product, effectively reduces weight and hepatic steatosis before transplantation. However, data on the outcomes of recipients of VLCD-treated donors are lacking. We conducted a single-center, retrospective study on 199 living donor liver transplant recipients at Toronto General Hospital, Canada, between January 2015 and January 2020. We compared the 1-year posttransplant outcomes between recipients who received organs from donors treated with VLCD (

Identifiers

PMID38725471

DOI10.1155/2024/9024204

PMCPMC11081753

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.